The Anti-inflammatory Effects of Ulinastatin in Trauma Patients with Hemorrhagic Shock

Overview

Journal J Korean Med Sci

Specialty General Medicine

Date 2010 Jan 7

PMID 20052358

Citations 14

Authors

Kyung Hye Park

Kang Hyun Lee

Hyun Kim

Sung Oh Hwang

Affiliations

Soon will be listed here.

Abstract

We investigated the use of ulinastatin in association with the suppression of polymorphonuclear leukocyte elastase (PMNE), tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6), and its effects on the prognosis of patients with traumatic hemorrhagic shock. Nineteen patients who visited the emergency department for traumatic hemorrhagic shock were enrolled. Eleven patients were randomly selected to receive a total of 300,000 IU of ulinastatin. Measurements of serum PMNE, TNF-alpha and IL-6 were taken before ulinastatin treatment at 24 hr, two days, three days, and seven days after admission. We compared the Systemic Inflammatory Response Syndrome scores, Multiple Organ Dysfunction Syndrome scores and Acute Physiology, age, Chronic Health Evaluation III scores of the control and ulinastatin groups. There were no significant differences in baseline values, laboratory data, treatment or mortality between the two groups. The serum PMNE levels in the ulinastatin group were lower than in the control group on the second hospitalized day. Serum TNF-alpha and IL-6 levels in the ulinastatin group decreased 24 hr after admission but had no significance. It is suggested that ulinastatin treatment could decrease the serum PMNE levels in trauma patients with hemorrhagic shock at 48 hr after treatment.

Citing Articles

Innate immunity and immunotherapy for hemorrhagic shock.

Huang Q, Gao S, Yao Y, Wang Y, Li J, Chen J Front Immunol. 2022; 13:918380.

PMID: 36091025 PMC: 9453212. DOI: 10.3389/fimmu.2022.918380.

Ulinastatin: A Potential Alternative to Glucocorticoid in the Treatment of Severe Decompression Sickness.

Meng W, Qing L, Li C, Zhang K, Yi H, Zhao X Front Physiol. 2020; 11:273.

PMID: 32273851 PMC: 7113395. DOI: 10.3389/fphys.2020.00273.

Ulinastatin did not reduce mortality in elderly multiple organ failure patients: a retrospective observational study in a single center ICU.

Uchida M, Abe T, Ono K, Tamiya N Acute Med Surg. 2018; 5(1):90-97.

PMID: 29445506 PMC: 5797838. DOI: 10.1002/ams2.304.

Therapeutic effect of ulinastatin on pulmonary fibrosis via downregulation of TGF‑β1, TNF‑α and NF‑κB.

Li D, Ji H, Zhao B, Xu C, Xia W, Han L Mol Med Rep. 2017; 17(1):1717-1723.

PMID: 29138863 PMC: 5780115. DOI: 10.3892/mmr.2017.8056.

Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions.

Huber-Lang M, Ekdahl K, Wiegner R, Fromell K, Nilsson B Semin Immunopathol. 2017; 40(1):87-102.

PMID: 28900700 PMC: 5794838. DOI: 10.1007/s00281-017-0646-9.

References

Ogawa M, Nishibe S, Mori T, Neumann S . Effect of human urinary trypsin inhibitor on granulocyte elastase activity. Res Commun Chem Pathol Pharmacol. 1987; 55(2):271-4. View

Toth B, Yokoyama Y, Schwacha M, George R, Rue 3rd L, Bland K . Insights into the role of interleukin-6 in the induction of hepatic injury after trauma-hemorrhagic shock. J Appl Physiol (1985). 2004; 97(6):2184-9. DOI: 10.1152/japplphysiol.00499.2004. View

Duswald K, Jochum M, Schramm W, Fritz H . Released granulocytic elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery. Surgery. 1985; 98(5):892-9. View

Tani T, Abe H, Endo Y, Hanasawa K, Kodama M . Effects of a urinary trypsin inhibitor on acute circulatory insufficiency after surgical operation. Am J Surg. 1998; 175(2):142-5. DOI: 10.1016/s0002-9610(97)00263-8. View

Sato Y, Ishikawa S, Otaki A, Takahashi T, Hasegawa Y, Suzuki M . Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin. Inhibiting cytokines and postoperative organ injury. Jpn J Thorac Cardiovasc Surg. 2000; 48(7):428-34. DOI: 10.1007/BF03218170. View

Yano T, Anraku S, Nakayama R, Ushijima K . Neuroprotective effect of urinary trypsin inhibitor against focal cerebral ischemia-reperfusion injury in rats. Anesthesiology. 2003; 98(2):465-73. DOI: 10.1097/00000542-200302000-00028. View

Neumann S, Gunzer G, HENNRICH N, Lang H . "PMN-elastase assay": enzyme immunoassay for human polymorphonuclear elastase complexed with alpha 1-proteinase inhibitor. J Clin Chem Clin Biochem. 1984; 22(10):693-7. View

MAITRA S, Gestring M, El-Maghrabi M . Alterations in hepatic 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and glucose-6-phosphatase gene expression after hemorrhagic hypotension and resuscitation. Shock. 1997; 8(5):385-8. DOI: 10.1097/00024382-199711000-00012. View

Tani T, Aoki H, Yoshioka T, Lin K, Kodama M . Treatment of septic shock with a protease inhibitor in a canine model: a prospective, randomized, controlled trial. Crit Care Med. 1993; 21(6):925-30. DOI: 10.1097/00003246-199306000-00023. View

10.

Brun-Buisson C . The epidemiology of the systemic inflammatory response. Intensive Care Med. 2000; 26 Suppl 1:S64-74. PMC: 7094973. DOI: 10.1007/s001340051121. View

11.

Riedemann N, Neff T, Guo R, Bernacki K, Laudes I, Sarma J . Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol. 2002; 170(1):503-7. DOI: 10.4049/jimmunol.170.1.503. View

12.

Aosasa S, Ono S, Mochizuki H, Tsujimoto H, Ueno C, Matsumoto A . Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes. Shock. 2001; 15(2):101-5. DOI: 10.1097/00024382-200115020-00004. View

13.

Nishiyama T, Hanaoka K . Do the effects of a protease inhibitor, ulinastatin, on elastase release by blood transfusion depend on interleukin 6?. Crit Care Med. 2001; 29(11):2106-10. DOI: 10.1097/00003246-200111000-00010. View

14.

Mania-Pramanik J, Potdar S, Vadigoppula A, Sawant S . Elastase: a predictive marker of inflammation and/or infection. J Clin Lab Anal. 2004; 18(3):153-8. PMC: 6808123. DOI: 10.1002/jcla.20015. View

15.

Pacholok S, Davies P, Dorn C, Finke P, Hanlon W, Mumford R . Formation of polymorphonuclear leukocyte elastase: alpha 1 proteinase inhibitor complex and A alpha (1-21) fibrinopeptide in human blood stimulated with the calcium ionophore A23187. A model to characterize inhibitors of polymorphonuclear leukocyte.... Biochem Pharmacol. 1995; 49(10):1513-20. DOI: 10.1016/0006-2952(95)00031-t. View

16.

Witthaut R, Busch C, Fraunberger P, Walli A, Seidel D, Pilz G . Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med. 2003; 29(10):1696-702. DOI: 10.1007/s00134-003-1910-0. View

17.

Lee C, Marill K, CARTER W, Crupi R . A current concept of trauma-induced multiorgan failure. Ann Emerg Med. 2001; 38(2):170-6. DOI: 10.1067/mem.2001.114313. View

18.

Chen C, Liu Z, Wang H, He W, Wang Y, Wu W . Effects of ulinastatin on renal ischemia-reperfusion injury in rats. Acta Pharmacol Sin. 2004; 25(10):1334-40. View

19.

Vallejo J, Nemoto S, Ishiyama M, Yu B, Knuefermann P, Diwan A . Functional significance of inflammatory mediators in a murine model of resuscitated hemorrhagic shock. Am J Physiol Heart Circ Physiol. 2005; 288(3):H1272-7. DOI: 10.1152/ajpheart.01003.2003. View

20.

Pugia M, Lott J . Pathophysiology and diagnostic value of urinary trypsin inhibitors. Clin Chem Lab Med. 2005; 43(1):1-16. DOI: 10.1515/CCLM.2005.001. View